Award Data

Location 1903 N HARRISON AVE, STE 101 CARY, NC 27513 United States N44MH0664102C $365 147.00 2 005 ADAPTING EXISTING CURRICULA FOR PROMOTING SOCIAL AND ADA Department of Health and Human Services National Institutes of Health SBIR PHS2006-1 THREE C INSTIT ...

The objective of this program is to develop a wide field of view spectral imaging sensor to support theater surveillance and intelligence. The AHS operates in the Mid Wave Infrared (MWIR) band and provides day/night spectral target cueing, geolocation and identification of hot battlefield threats. Currently deployed EO sensors can measure broadband MWIR signals, but are incapable of providing adva ...

Taggants are small objects used to label things or people that need to be traced. Synthetic DNA Taggants are ideal for this, since very small amounts can be detected if the sequence is known, and can be disguised by natural DNA in the environment. Known protocols for DNA amplification (e.g. PCR) allow for very sensitive DNA detection, but suffer from disadvantages: the apparatus is not very portab ...

DESCRIPTION (provided by applicant): We propose to conduct a clinical trial using a suite of web-based software products as well as a web portal that will help with standardized assessment, treatment planning, referral, and outcomes tracking for adolescent substance abuse treatment. Products will include the automated Internet version of the Self- Report Teen-Addiction Severity Index (SR-T-ASI Net ...

DESCRIPTION (provided by applicant): The success of research-based prevention programs depends on the degree to which they are implemented with fidelity. This Phase II project will enhance All Stars, a drug abuse prevention program, by integrating web-based and multimedia technologies. Enhancements will improve program fidelity by making the program easier to deliver. They will improve effectivene ...

N/A

DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of genes against distinct gene expression patterns induced by chemical/biological agents to provide early identification and speed therapeutic intervention. The overall objective of this Phase II effort is to leverage existing public domain resources and commercial tools t ...

DESCRIPTION (provided by applicant): The ultimate goal of this project is treatment of beta-thalassemia, a genetic blood disease, with antisense oligonucleotides. The project is based on the technology developed by the PI in which antisense oligonucleotides are used to restore correct functioning of a defective gene rather than, as commonly practiced, to inhibit the expression of an undesirable ge ...

DESCRIPTION (provided by applicant): The ultimate goal of this project is treatment of beta-thalassemia, a genetic blood disease, with antisense oligonucleotides. The project is based on the technology developed by the PI in which antisense oligonucleotides are used to restore correct functioning of a defective gene rather than, as commonly practiced, to inhibit the expression of an undesirable ge ...

DESCRIPTION (provided by applicant): In its Roadmap Initiatives, NIH has highlighted the need for improvement in dynamic assessments in health care and for the use of new technology in the collection of patient-reported outcomes (PRO). The goal of this project is to further validate a new mental health outcomes-tracking instrument for depression, anxiety, social functioning, and occupational funct ...